MedAngels
Egypt, Arkansas, United States
Overview
Med Angels is a federation of Mediterranean angel networks. As a network of networks, we are focused on facilitating cross-border investing and syndicating deals among participating Mediterranean angel networks.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 0
Investment portfolio
- NEMA HEALTH
Participated · Seed · Mar 2026
NEMA HEALTH develops Onconeovac, a personalized immunotherapy that combines tumor neoantigens with patented DIF immunostimulatory peptides. The program is currently focused on advanced/metastatic melanoma and aims to be used in combination with other therapies; preclinical animal studies showed tumor prevention and growth reduction comparable to anti‑PD1 and up to fourfold greater reduction when combined with anti‑PD1. The company intends to accelerate preclinical development and investigate applications in other solid tumors and in veterinary oncology. NEMA HEALTH originated as a spin-off from VHIR and the University of Lleida through The Collider program. The recent seed raise and NEOTEC grant are being used to scale peptide manufacturing capacity via BCN Peptides and to professionalize the company’s structure, including the formation of a new board of directors.
Team
No current team members are available.